AAAAAA
Results:
1-19
|
Results: 19
Authors:
Blanke, CD
Haller, DG
Benson, AB
Rothenberg, ML
Berlin, J
Mori, M
Hsieh, YC
Miller, LL
Citation: Cd. Blanke et al., A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma, ANN ONCOL, 12(11), 2001, pp. 1575-1580
Authors:
O'Dwyer, PJ
Manola, J
Valone, FH
Ryan, LM
Hines, JD
Wadler, S
Haller, DG
Arbuck, SG
Weiner, LM
Mayer, RJ
Benson, AB
Citation: Pj. O'Dwyer et al., Fluorouracil modulation in colorectal cancer: Lack of improvement with N-phosphonoacetyl-l-aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule - An Eastern Cooperative Oncology Group/Cancer and Leukemia Group B study, J CL ONCOL, 19(9), 2001, pp. 2413-2421
Authors:
Tepper, JE
O'Connell, MJ
Niedzwiecki, D
Hollis, D
Compton, C
Benson, AB
Cummings, B
Gunderson, L
Macdonald, JS
Mayer, RJ
Citation: Je. Tepper et al., Impact of number of nodes retrieved on outcome in patients with rectal cancer, J CL ONCOL, 19(1), 2001, pp. 157-163
Authors:
Sitzung, Z
Benson, AB
Goldberg, RM
Citation: Z. Sitzung et al., Oxaliplatin (Eloxatin) - Advances in cancer therapy 2001 - Introduction, ONKOLOGIE, 24, 2001, pp. 1-8
Authors:
Yao, KA
Talamonti, MS
Nemcek, A
Angelos, P
Chrisman, H
Skarda, J
Benson, AB
Rao, S
Joehl, RJ
Citation: Ka. Yao et al., Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors, SURGERY, 130(4), 2001, pp. 677-682
Authors:
Watanabe, T
Wu, T
Catalano, PJ
Ueki, T
Satriano, R
Benson, AB
Hamilton, SR
Citation: T. Watanabe et al., Molecular predictors of survival after adjuvant chemotherapy for colon cancer., N ENG J MED, 344(16), 2001, pp. 1196-1206
Authors:
Benson, AB
Olopade, OI
Ratain, MJ
Rademaker, A
Mobarhan, S
Stucky-Marshall, L
French, S
Dolan, ME
Citation: Ab. Benson et al., Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (oltipraz) in patients with previously resected colon polyps and first-degree female relatives of breast cancer patients, CLIN CANC R, 6(10), 2000, pp. 3870-3877
Authors:
Kornblau, S
Benson, AB
Catalano, R
Champlin, RE
Engelking, C
Field, M
Ippoliti, C
Lazarus, HM
Mitchell, E
Rubin, J
Stiff, PJ
Vokes, E
Wadler, S
Citation: S. Kornblau et al., Management of cancer treatment-related diarrhea: Issues and therapeutic strategies, J PAIN SYMP, 19(2), 2000, pp. 118-129
Authors:
Benson, AB
Desch, CE
Flynn, PJ
Krause, C
Loprinzi, CL
Minsky, BD
Petrelli, NJ
Pfister, DG
Smith, TJ
Somerfield, MR
Citation: Ab. Benson et al., 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines, J CL ONCOL, 18(20), 2000, pp. 3586-3588
Authors:
Talamonti, MS
Catalano, PJ
Vaughn, DJ
Whittington, R
Beauchamp, RD
Berlin, J
Benson, AB
Citation: Ms. Talamonti et al., Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapyin patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity, J CL ONCOL, 18(19), 2000, pp. 3384-3389
Authors:
Harris, JE
Ryan, L
Hoover, HC
Stuart, RK
Oken, MM
Benson, AB
Mansour, E
Haller, DG
Manola, J
Hanna, MG
Citation: Je. Harris et al., Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group study E5283, J CL ONCOL, 18(1), 2000, pp. 148-157
Authors:
Kucuk, O
Kilton, L
Wade, JL
Blough, R
Benson, AB
Citation: O. Kucuk et al., Phase II trial of menogaril in patients with previously treated multiple myeloma or chronic lymphocytic leukemia, AM J CL ONC, 23(4), 2000, pp. 379-383
Authors:
Asbury, RF
Lipsitz, S
Graham, D
Falkson, CI
Baez, L
Benson, AB
Citation: Rf. Asbury et al., Treatment of squamous cell esophageal cancer with topotecan - An Eastern Cooperative Oncology Group study (E2293), AM J CL ONC, 23(1), 2000, pp. 45-46
Authors:
Gradishar, WJ
Soff, G
Liu, JG
Cisneros, A
French, S
Rademaker, A
Benson, AB
Bouck, N
Citation: Wj. Gradishar et al., A pilot trial of suramin in metastatic breast cancer to assess antiangiogenic activity in individual patients, ONCOL-BASEL, 58(4), 2000, pp. 324-333
Authors:
Berlin, JD
Adak, S
Vaughn, DJ
Flinker, D
Blaszkowsky, L
Harris, JE
Benson, AB
Citation: Jd. Berlin et al., A phase II study of gemcitabine and 5-fluorouracil in metastatic pancreatic cancer: An Eastern Cooperative Oncology Group Study (E3296), ONCOL-BASEL, 58(3), 2000, pp. 215-218
Authors:
Benson, AB
Citation: Ab. Benson, NCCN practice guidelines for hepatobiliary cancers, ONCOLOGY-NY, 13(11A), 1999, pp. 265-291
Authors:
Desch, CE
Benson, AB
Smith, TJ
Flynn, PJ
Krause, C
Loprinzi, CL
Minsky, BD
Petrelli, NJ
Pfister, DG
Somerfield, MR
Citation: Ce. Desch et al., Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology, J CL ONCOL, 17(4), 1999, pp. 1312-1321
Authors:
Minsky, BD
Neuberg, D
Kelsen, DP
Pisansky, TM
Ginsberg, RJ
Pajak, T
Salter, M
Benson, AB
Citation: Bd. Minsky et al., Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus, INT J RAD O, 43(3), 1999, pp. 517-523
Authors:
Talamonti, MS
Tellez, C
Benson, AB
Citation: Ms. Talamonti et al., Local-regional therapy for metastatic liver tumors, CANC TREAT, 98, 1998, pp. 173-199
Risultati:
1-19
|